A study aimed at reducing racial disparities in urine testing of pregnant patients showed that a change in testing policy along with an electronic clinical decision support tool led to significant improvements[1]. Before the interventions, 23.2% of black patients and 11.1% of white patients were tested, a significant racial difference[1]. After the implementation of the new program, the proportion of female patients tested decreased to 4.5% for black and 3.6% for white patients, while the racial difference was no longer statistically significant[1]. The intervention was to remove isolated cannabis use and inadequate prenatal care as indications for testing[1]. At the same time, the ability to identify clinically relevant use of other non-scratched substances did not change significantly[1]. A study confirmed that improving the fairness of urine testing does not reduce the detection of actual substance abuse[1].